Illinois 2025-2026 Regular Session

Illinois Senate Bill SB1390 Latest Draft

Bill / Introduced Version Filed 01/29/2025

                            104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 SB1390 Introduced 1/29/2025, by Sen. David Koehler SYNOPSIS AS INTRODUCED: 305 ILCS 5/5-36a new Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall not enter into a contract with a managed care organization that relies on a pharmacy benefit manager that does not do the following: (i) utilize a pharmacy reimbursement methodology of the lesser of national average drug acquisition cost plus a professional dispensing fee as determined by the Department, the wholesale acquisition cost plus a professional dispensing fee as determined by the Department, or the usual and customary charge by the pharmacy; (ii) reimburse for a legally valid claim at a rate not less than the rate in effect at the time the original claim adjudication was submitted at the point of sale; (iii) agree to move to a transparent pass-through pricing model, in which the pharmacy benefit manager discloses the administrative fee as a percentage of the professional dispensing costs to the Department; (iv) agree to not create new pharmacy administration fees and to not increase current fees more than the rate of inflation; and (v) agree to not terminate an existing contract with a pharmacy licensed under the Pharmacy Practice Act for the sole reason of the additional professional dispensing fee authorized under item (i). Requires each pharmacy benefit manager that receives reimbursement for medical services, either directly or through a Medicaid managed care health plan, to submit by January 15, 2027, and each January 15 thereafter, certain data and information to the Department for the previous fiscal year, including: (1) the total number of prescriptions that were dispensed; (2) the aggregate wholesale acquisition cost for each drug on its formulary; (3) the aggregate amount of rebates, discounts, and price concessions that the pharmacy benefit manager received for each drug on its formulary; (4) the aggregate amount of administrative fees that the pharmacy benefit manager received from all pharmaceutical manufacturers; and (5) any other information considered necessary by the Department. Requires the Department to submit such data and information to the General Assembly and to the Governor's Office of Management and Budget. Provides that such information is confidential and not subject to disclosure under the Freedom of Information Act. LRB104 08735 KTG 18789 b   A BILL FOR 104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 SB1390 Introduced 1/29/2025, by Sen. David Koehler SYNOPSIS AS INTRODUCED:  305 ILCS 5/5-36a new 305 ILCS 5/5-36a new  Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall not enter into a contract with a managed care organization that relies on a pharmacy benefit manager that does not do the following: (i) utilize a pharmacy reimbursement methodology of the lesser of national average drug acquisition cost plus a professional dispensing fee as determined by the Department, the wholesale acquisition cost plus a professional dispensing fee as determined by the Department, or the usual and customary charge by the pharmacy; (ii) reimburse for a legally valid claim at a rate not less than the rate in effect at the time the original claim adjudication was submitted at the point of sale; (iii) agree to move to a transparent pass-through pricing model, in which the pharmacy benefit manager discloses the administrative fee as a percentage of the professional dispensing costs to the Department; (iv) agree to not create new pharmacy administration fees and to not increase current fees more than the rate of inflation; and (v) agree to not terminate an existing contract with a pharmacy licensed under the Pharmacy Practice Act for the sole reason of the additional professional dispensing fee authorized under item (i). Requires each pharmacy benefit manager that receives reimbursement for medical services, either directly or through a Medicaid managed care health plan, to submit by January 15, 2027, and each January 15 thereafter, certain data and information to the Department for the previous fiscal year, including: (1) the total number of prescriptions that were dispensed; (2) the aggregate wholesale acquisition cost for each drug on its formulary; (3) the aggregate amount of rebates, discounts, and price concessions that the pharmacy benefit manager received for each drug on its formulary; (4) the aggregate amount of administrative fees that the pharmacy benefit manager received from all pharmaceutical manufacturers; and (5) any other information considered necessary by the Department. Requires the Department to submit such data and information to the General Assembly and to the Governor's Office of Management and Budget. Provides that such information is confidential and not subject to disclosure under the Freedom of Information Act.  LRB104 08735 KTG 18789 b     LRB104 08735 KTG 18789 b   A BILL FOR
104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 SB1390 Introduced 1/29/2025, by Sen. David Koehler SYNOPSIS AS INTRODUCED:
305 ILCS 5/5-36a new 305 ILCS 5/5-36a new
305 ILCS 5/5-36a new
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall not enter into a contract with a managed care organization that relies on a pharmacy benefit manager that does not do the following: (i) utilize a pharmacy reimbursement methodology of the lesser of national average drug acquisition cost plus a professional dispensing fee as determined by the Department, the wholesale acquisition cost plus a professional dispensing fee as determined by the Department, or the usual and customary charge by the pharmacy; (ii) reimburse for a legally valid claim at a rate not less than the rate in effect at the time the original claim adjudication was submitted at the point of sale; (iii) agree to move to a transparent pass-through pricing model, in which the pharmacy benefit manager discloses the administrative fee as a percentage of the professional dispensing costs to the Department; (iv) agree to not create new pharmacy administration fees and to not increase current fees more than the rate of inflation; and (v) agree to not terminate an existing contract with a pharmacy licensed under the Pharmacy Practice Act for the sole reason of the additional professional dispensing fee authorized under item (i). Requires each pharmacy benefit manager that receives reimbursement for medical services, either directly or through a Medicaid managed care health plan, to submit by January 15, 2027, and each January 15 thereafter, certain data and information to the Department for the previous fiscal year, including: (1) the total number of prescriptions that were dispensed; (2) the aggregate wholesale acquisition cost for each drug on its formulary; (3) the aggregate amount of rebates, discounts, and price concessions that the pharmacy benefit manager received for each drug on its formulary; (4) the aggregate amount of administrative fees that the pharmacy benefit manager received from all pharmaceutical manufacturers; and (5) any other information considered necessary by the Department. Requires the Department to submit such data and information to the General Assembly and to the Governor's Office of Management and Budget. Provides that such information is confidential and not subject to disclosure under the Freedom of Information Act.
LRB104 08735 KTG 18789 b     LRB104 08735 KTG 18789 b
    LRB104 08735 KTG 18789 b
A BILL FOR
SB1390LRB104 08735 KTG 18789 b   SB1390  LRB104 08735 KTG 18789 b
  SB1390  LRB104 08735 KTG 18789 b
1  AN ACT concerning public aid.
2  Be it enacted by the People of the State of Illinois,
3  represented in the General Assembly:
4  Section 5. The Illinois Public Aid Code is amended by
5  adding Section 5-36a as follows:
6  (305 ILCS 5/5-36a new)
7  Sec. 5-36a. Managed care organizations; pharmacy benefit
8  managers; contract requirements.
9  (a) Notwithstanding any law or rule to the contrary, the
10  Department shall not enter into a contract with a managed care
11  organization that relies on a pharmacy benefit manager that
12  does not do all of the following:
13  (1) For pharmacies licensed under the Pharmacy
14  Practice Act, including offsite institutional pharmacies
15  as defined in Section 39.5 of the Pharmacy Practice Act,
16  utilize a pharmacy reimbursement methodology of the lesser
17  of national average drug acquisition cost plus a
18  professional dispensing fee as determined by the
19  Department, the wholesale acquisition cost plus a
20  professional dispensing fee as determined by the
21  Department, or the usual and customary charge by the
22  pharmacy. The pharmacy benefit manager or the involved
23  pharmacy services administrative organization, as defined

 

104TH GENERAL ASSEMBLY
 State of Illinois
 2025 and 2026 SB1390 Introduced 1/29/2025, by Sen. David Koehler SYNOPSIS AS INTRODUCED:
305 ILCS 5/5-36a new 305 ILCS 5/5-36a new
305 ILCS 5/5-36a new
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall not enter into a contract with a managed care organization that relies on a pharmacy benefit manager that does not do the following: (i) utilize a pharmacy reimbursement methodology of the lesser of national average drug acquisition cost plus a professional dispensing fee as determined by the Department, the wholesale acquisition cost plus a professional dispensing fee as determined by the Department, or the usual and customary charge by the pharmacy; (ii) reimburse for a legally valid claim at a rate not less than the rate in effect at the time the original claim adjudication was submitted at the point of sale; (iii) agree to move to a transparent pass-through pricing model, in which the pharmacy benefit manager discloses the administrative fee as a percentage of the professional dispensing costs to the Department; (iv) agree to not create new pharmacy administration fees and to not increase current fees more than the rate of inflation; and (v) agree to not terminate an existing contract with a pharmacy licensed under the Pharmacy Practice Act for the sole reason of the additional professional dispensing fee authorized under item (i). Requires each pharmacy benefit manager that receives reimbursement for medical services, either directly or through a Medicaid managed care health plan, to submit by January 15, 2027, and each January 15 thereafter, certain data and information to the Department for the previous fiscal year, including: (1) the total number of prescriptions that were dispensed; (2) the aggregate wholesale acquisition cost for each drug on its formulary; (3) the aggregate amount of rebates, discounts, and price concessions that the pharmacy benefit manager received for each drug on its formulary; (4) the aggregate amount of administrative fees that the pharmacy benefit manager received from all pharmaceutical manufacturers; and (5) any other information considered necessary by the Department. Requires the Department to submit such data and information to the General Assembly and to the Governor's Office of Management and Budget. Provides that such information is confidential and not subject to disclosure under the Freedom of Information Act.
LRB104 08735 KTG 18789 b     LRB104 08735 KTG 18789 b
    LRB104 08735 KTG 18789 b
A BILL FOR

 

 

305 ILCS 5/5-36a new



    LRB104 08735 KTG 18789 b

 

 



 

  SB1390  LRB104 08735 KTG 18789 b


SB1390- 2 -LRB104 08735 KTG 18789 b   SB1390 - 2 - LRB104 08735 KTG 18789 b
  SB1390 - 2 - LRB104 08735 KTG 18789 b
1  in Section 5-36 of this Code, shall not receive any
2  portion of the professional dispensing fee. The Department
3  shall identify the pharmacies this subsection applies to
4  and provide the list of applicable pharmacies to managed
5  care organizations contracted with the Department.
6  (2) Reimburse for a legally valid claim at a rate not
7  less than the rate in effect at the time the original claim
8  adjudication was submitted at the point of sale.
9  (3) Agree to move to a transparent pass-through
10  pricing model, in which the pharmacy benefit manager
11  discloses the administrative fee as a percentage of the
12  professional dispensing costs to the Department.
13  (4) Agree to not create new pharmacy administration
14  fees and to not increase current fees more than the rate of
15  inflation. This paragraph does not apply to any federal
16  rule or action that creates a new fee.
17  (5) Agree to not terminate an existing contract with a
18  pharmacy licensed under the Pharmacy Practice Act for the
19  sole reason of the additional professional dispensing fee
20  authorized under this Section.
21  (b) Nothing in this Section shall be construed to prohibit
22  a managed care organization from implementing the provisions
23  of subsection (a) before the effective date of this amendatory
24  Act of the 104th General Assembly.
25  (c) By January 15, 2027 and each January 15 thereafter,
26  each pharmacy benefit manager that receives reimbursement,

 

 

  SB1390 - 2 - LRB104 08735 KTG 18789 b


SB1390- 3 -LRB104 08735 KTG 18789 b   SB1390 - 3 - LRB104 08735 KTG 18789 b
  SB1390 - 3 - LRB104 08735 KTG 18789 b
1  either directly or through a Medicaid managed care health
2  plan, for medical services must submit all of the following
3  information to the Department for the previous fiscal year:
4  (1) The total number of prescriptions that were
5  dispensed.
6  (2) The aggregate wholesale acquisition cost for each
7  drug on its formulary.
8  (3) The aggregate amount of rebates, discounts, and
9  price concessions that the pharmacy benefit manager
10  received for each drug on its formulary. The amount of
11  rebates shall include any utilization discounts the
12  pharmacy benefit manager receives from a manufacturer.
13  (4) The aggregate amount of administrative fees that
14  the pharmacy benefit manager received from all
15  pharmaceutical manufacturers.
16  (5) The aggregate amount identified in paragraphs (2)
17  and (3) that was retained by the pharmacy benefit manager
18  and did not pass through to the Department or to the
19  Medicaid managed care health plan.
20  (6) The aggregate amount of reimbursements the
21  pharmacy benefit manager pays to contracting pharmacies.
22  (7) Any other information considered necessary by the
23  Department.
24  (d) By March 1, 2027 and each March 1 thereafter, the
25  Department shall submit the information provided under
26  subsection (c) to the General Assembly and the Governor's

 

 

  SB1390 - 3 - LRB104 08735 KTG 18789 b


SB1390- 4 -LRB104 08735 KTG 18789 b   SB1390 - 4 - LRB104 08735 KTG 18789 b
  SB1390 - 4 - LRB104 08735 KTG 18789 b

 

 

  SB1390 - 4 - LRB104 08735 KTG 18789 b